Table 3.
Identified differential metabolites between two groups.
| Name | MW | RT | VIP | FC | P | Label |
|---|---|---|---|---|---|---|
| Choline | 103.1 | 0.7 | 3.3 | 1.79 | 0.003 | Up |
| Trigonelline | 137.0 | 0.7 | 2.1 | 3.19 | 0.016 | up |
| N-acetylputrescine | 130.1 | 0.7 | 1.8 | 1.23 | 0.009 | up |
| Pseudoephedrine | 165.1 | 3.3 | 2.5 | 0.01 | 0.009 | down |
| N8-acetylspermidine | 187.2 | 0.7 | 2.4 | 1.43 | 0.004 | up |
| Glycocholate | 465.3 | 8.0 | 2.2 | 4.06 | 0.013 | up |
| Uric acid | 168.0 | 1.0 | 1.9 | 1.66 | 0.021 | up |
| Ecgonine | 185.1 | 4.9 | 1.8 | 1.96 | 0.028 | up |
| 1-methylnicotinamide | 136.1 | 0.8 | 1.8 | 2.09 | 0.012 | up |
| 6-methylquinoline | 143.1 | 3.5 | 1.6 | 0.63 | 0.035 | down |
| Sebacic acid | 202.1 | 6.4 | 1.6 | 1.97 | 0.049 | up |
| Picolinic acid | 123.0 | 3.5 | 1.5 | 0.64 | 0.012 | down |
| 3-hydroxyanthranilic acid | 153.0 | 2.8 | 1.1 | 1.26 | 0.049 | up |
| Mannitol | 182.1 | 0.7 | 1.9 | 1.57 | 0.022 | up |
| Carbendazim | 191.1 | 0.7 | 1.6 | 0.15 | 0.023 | down |
| Lipoamide | 205.1 | 4.0 | 1.4 | 1.78 | 0.033 | up |
| Ophthalmic acid | 289.1 | 2.4 | 1.4 | 0.47 | 0.041 | down |
| Valerophenone | 162.1 | 5.5 | 1.2 | 0.71 | 0.030 | down |
| D-(-)-lyxose | 150.1 | 0.7 | 1.0 | 0.77 | 0.030 | down |
| Creatine | 131.1 | 0.7 | 1.6 | 0.32 | 0.030 | down |
| L-glutamic acid | 147.1 | 0.7 | 1.1 | 0.71 | 0.029 | down |
| Methylmalonic acid | 118.0 | 0.7 | 1.9 | 0.46 | 0.014 | down |
| Porphobilinogen | 226.1 | 0.7 | 1.5 | 0.49 | 0.001 | down |
| Epinephrine | 183.1 | 3.9 | 2.2 | 2.44 | 0.008 | up |
| Heptanoic acid | 130.1 | 5.4 | 1.4 | 0.50 | 0.047 | down |
| 11-dehydrothromboxane b2 | 368.2 | 6.8 | 1.1 | 1.40 | 0.040 | up |
| Nonanoic acid | 158.1 | 6.9 | 1.5 | 0.51 | 0.004 | down |
| Taurolithocholic acid 3-sulfate | 563.3 | 7.8 | 2.2 | 1.53 | 0.017 | up |
VIP, variable important for the projection; FC, fold-change; MW, molecular weight; RT, retention time.